CEVA

altresyn-logo

altresynEfficiency of achieving weekly output, in terms of sow and gilt farrowings, is a key component for effective reproduction management and efficiency. Ineffective flow management results in a large variation both between and within weekly service numbers. This will directly cause problems with the effective utilisation of valuable farrowing accommodation. The organisation of gilt introduction is a key driver for achieving consistent output, due to a direct beneficial effect on total number of services per week. Opportunity exists using Altresyn®, to effectively achieve gilt synchronisation and consistent gilt numbers.


The Altresyn app

altresynAltresyn® is supported by the Altresyn® app which allows easy tracking of batches of gilts being treated, as well as a calculator to ensure you are bringing in the correct number of gilts per batch for your production system. Batch treatment schedules can also be emailed directly from the app which is very useful for farm records and ensuring the correct treatment is given.

Please watch the videos below where Emma will take you through a step by step guide to downloading and using the Altresyn® app.

Introduction and Downloading the Altresyn® App
https://youtu.be/3UIQkltktmc

Setting up a batch in the Altresyn® App
https://youtu.be/pLJwJE3oKaM

Additional Altresyn® App features
https://youtu.be/FmL8e3iwUpU

For further information, contact Emma Pattison on 07734 779899 or [email protected]


The Ceva Reproductive Program

The Ceva Reproductive Program (CRP) is a user friendly, web-based system which has been created with the aim to emphasise the benefits of consistent reproduction and therefore consistent production flow throughout a unit instead of just focussing on hitting the ‘average’ target. Current pressure points due to stocking rates will be highlighted within the website, indicated by a dial system, displaying as under, optimal or over stocked for each production stage. Producing uniform batches of pigs is key in achieving optimal production and minimising economic losses. The impact of overstocking on growth and performance of animals is well documented and this forms the basis of the economic calculations for the growing pigs. Calculations are also in place to determine the cost of an empty crate in the farrowing accommodation.

Please watch the videos below where Emma will take you through a step by step guide to using and making the most of the CRP.

Introduction to the Ceva Reproductive Program (CRP)
https://youtu.be/_iw51GbiwtA

Inputting data to the CRP
https://youtu.be/2IbGcA7dBOI

Summary tab on the CRP
https://youtu.be/gb-FbiZCt9I

Week tab on the CRP
https://youtu.be/u2yee8Zcbf4

Reproduction tab on the CRP
https://youtu.be/BqHszwT7iaI

Production flow tab on the CRP
https://youtu.be/H6TfHNBNvLQ

Economics tab on the CRP
https://youtu.be/F2rRnn_EwBk

A summary of the Ceva Reproductive Program (CRP)
https://youtu.be/Ti7h3aUJVGU

For further information, contact Emma Pattison on 07734 779899 or [email protected]


Respiporc Flu3 and Flupan H1N1

ceva-2

 

Hyogen

hyogenMycoplasma hyopneumoniae, associated with enzootic pneumonia, plays a major role in the porcine respiratory disease complex (PRDC) and can cause huge economic losses. A 17% decrease in daily weight gain and a 14% decrease in feed efficiency has been reported in herds with enzootic pneumonia.

Mycoplasma hyopneumoniae is unable to penetrate and live within host cells but does colonise the mucosal surface of the ciliated epithelium of the respiratory system. In addition to the detrimental effect on the cilia, Mycoplasma hyopneumoniae infection attracts lymphocytes and macrophages into the lungs resulting in pneumonia. Protection against the infection requires complex activation of the host immune system.

After a single injection, Hyogen® provides effective protection against Mycoplasma hyopneumoniae due to the potent stimulation of the immune system by the antigen originated from Ceva Mycoplasma hyopneumoniae strain BA 2940-99 along with the adjuvant, Imuvant™.

Key features:

  • A single vaccination at 21 days of age provides early and long-lasting protection for up to 26 weeks
  • Contains the highly potent Ceva proprietary strain BA 2940-99
  • Imuvant™, a unique Ceva adjuvant
Brochure

Brochure

Brochure

Data and economics


Contact us for more information at [email protected] or 01494 781510.

Coglapix

coglapixCoglapix® provides cross-serotype protection against Actinobacillus pleuropneumoniae (A.p). This effective protection, without post vaccination reactions, gives each pig the ability to breathe easily and therefore gain without pain.

Porcine pleuropneumonia caused by Actinobacillus pleuropneumoniae (A.p.) is a highly contagious respiratory disease, characterised by rapid onset, short course, high morbidity and mortality. The disease spreads worldwide and there are various levels of perception, diagnostic and monitoring measures available in addition to preventive programs.

Pleuropneumonia mostly affects growing and finishing pigs, but can also be present in nursery pigs and gilts. It can appear as a singular disease, or more frequently as an important part of the porcine respiratory disease complex (PRDC). Correct diagnostics and implementation of appropriate monitoring methods are important factors for the success of preventive measures applied to the control of the disease.

coglapix-brochure


Ceva Lung Program

The Ceva Lung Program offers the methodology and guidelines on how to correctly evaluate the presence, incidence, circulation patterns and impact of Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae and Aujeszky’s disease virus infections using serological investigation and adapted lung scoring of slaughter pigs.

The Ceva Lung Program Scoring methodology is designed to assist in identifying the correct diagnosis of respiratory disease through the evaluation of lungs at slaughter. It also enables the discovery of subclinical infections that were not noted during the growing period

ceva-lung

Get Our E-Newsletter - Pig World's best stories in your in-box twice a week
Will be used in accordance with our Privacy Policy